This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Cincinnati Office of Continuing Medical Education, EMCREG-International and TotalCME, Inc.
The University of Cincinnati is accredited by the ACCME to provide continuing medical education for physicians.
The University of Cincinnati designates each live activity for a maximum of 0.5 AMA PRA Category 1 Credits™
. Physicians should claim only the credits commensurate with the extent of their participation in the activity.
In accordance with the ACCME Standards for Commercial Support of CME, the speakers for this course have been asked to disclose to participants the existence of any financial interest and/or relationship(s) (e.g., paid speaker, employee, paid consultant on a board and/or committee for a commercial company) that would potentially affect the objectivity of his/her presentation or whose products or services may be mentioned during their presentation. The following disclosures were made:
Planning Committee Members
W. Brian Gibler, MD - Entegrion: Board Member, Advisor, Shareholder; EMCREG-International: Board Member, Shareholder
Bruce Gebhardt, MD - University of Cincinnati Reviewer - No relevant relationships
Susan P. Tyler - No relevant relationships
Barb Forney - No relevant relationships
Susan Diaz, Coordinator – No relevant relationships
Vinod Kalathiveetil, PharmD – No relevant relationships
Jordan Bonomo, MD – No relevant relationships
Rhonda Cadena, MD – No relevant relationships
Brian Fuller, MD – No relevant relationships
William Knight, IV MD – No relevant relationships
W. Frank Peacock, MD – Grants/research support recipient: AstraZeneca & Relypsa
Off-Label Disclosure Statement
Faculty members are required to inform the audience when they are discussing off-label, unapproved uses of devices and drugs. Physicians should consult full prescribing information before using any product mentioned during this educational activity.
Learner Assurance Statement
The University of Cincinnati is committed to resolving all conflicts of interest issues that could arise as a result of prospective faculty members’ significant relationships with drug or device manufacturer(s). The University of Cincinnati is committed to retaining only those speakers with financial interests that can be reconciled with the goals and educational integrity of the CME activity.
The opinions expressed during the live activity are those of the faculty and do not necessarily represent the views of the University of Cincinnati. The information is presented for the purpose of advancing the attendees' professional development.
There is no fee for these educational activities.
A statement of credit will be issued only upon receipt of a completed activity evaluation form and will be emailed to you within three weeks.
This activity is supported in part by an independent educational grant from AstraZeneca.
Jointly provided by University of Cincinnati College of Medicine Office of Continuing Medical Education, EMCREG-International, and TotalCME.